Was amorphous aluminium hydroxyphosphate sulfate adequately evaluated before authorisation in Europe?

The Merck Sharp & Dohme Corp aluminium adjuvant ‘amorphous aluminium hydroxyphosphate sulfate’ (AAHS), primarily used in the Gardasil vaccines against human papilloma virus, has been criticised for lack of evidence for its safety. Documentation from Danish authorities and answers from the Europe...

Descripción completa

Detalles Bibliográficos
Autores principales: Petersen, Sesilje B, Gluud, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
EBM analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639934/
https://www.ncbi.nlm.nih.gov/pubmed/32763959
http://dx.doi.org/10.1136/bmjebm-2020-111419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639934/
https://www.ncbi.nlm.nih.gov/pubmed/32763959
http://dx.doi.org/10.1136/bmjebm-2020-111419

Ejemplares similares